Clinical trial Recruiting at 1 site Interventional Ages 18 to 40

Single-session myofascial release for text neck

Official title: Exploring the Short-Term Effects of Myofascial Release in Text Neck Syndrome

Run by Karabuk University · NCT06991387 · Data updated 2026-11-12

This trial will see if one session of myofascial release can quickly reduce neck pain and improve neck movement in adults 18–40 who use mobile devices more than 3 hours a day and have text neck.

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexAll
Enrollment20 (estimated)
SponsorKarabuk University
Academic / other
Locations1 site (Karabük, Karabük Province)
StatusRecruiting
StartedMay 10, 2025
Main results expectedJune 2025
Study endsAugust 2025
Registry record updatedJune 5, 2025
Trial IDNCT06991387 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–40 who use mobile devices at least 3 hours per day, meet the diagnostic criteria for text neck, and can safely receive manual therapy are ideal candidates.

Probably not a fit

People with congenital, traumatic, surgical, inflammatory, or infectious cervical/spinal conditions, diagnosed spinal deformities, certain neurological headache disorders, or recent cervical trigger-point injections may not benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-arm, single-session study at Karabük University applying four standardized myofascial release techniques to the cervical and upper thoracic regions delivered by a licensed physiotherapist. Eligible participants (aged 18–40, using mobile devices ≥3 hours/day, with at least three text-neck symptoms) will have pain intensity (NRS-11), cervical range of motion, and the modified Neck Disability Index measured immediately before and after the intervention. The intervention sequence includes Single Arm Pull, Lateral Neck Shoulder Release, Thoracic Transverse Release, and Anterior Cervical Release. The study focuses on acute, immediate changes after one treatment rather than long-term outcomes.

Why it matters

Potential benefit: If effective, the technique could provide immediate short-term pain relief and improved neck mobility as a non-invasive option for people with text neck.

How similar studies have gone: Some small trials and manual therapy research report short-term pain and mobility benefits from myofascial or soft-tissue techniques, but high-quality evidence specific to text neck is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged between 18 and 40 years (inclusive)
* Uses a mobile device for ≥3 hours/day
* Reports at least 3 out of the following 6 symptoms associated with Text Neck Syndrome (TNS):

Neck pain Shoulder pain Back pain Headache Insomnia Numbness/tingling in hands

-Voluntarily agrees to participate and provides informed consent

Exclusion Criteria:

* History of congenital, traumatic, or surgical pathology affecting the cervical -------spine or shoulder region
* Neurological disorders that cause headaches (e.g., migraines due to underlying neurological conditions)
* Presence of inflammatory, infectious spinal diseases, or diagnosed spinal deformities
* Received trigger point injections in the cervical region within the past 6 months

Where it's running

  • Karabük University
    Karabük, Karabük Province, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.